跳至主要内容
临床试验/ITMCTR2100004352
ITMCTR2100004352招募中1 期

Clinical study on acupuncture intervention of 'Siguan point' on nausea and vomiting induced by high emetic chemotherapy in patients with breast cancer

China-Japan Friendship Hospital0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 75(—)
性别
Female

入选标准

  • 1. Patients with breast cancer confirmed by pathology and meeting the chemotherapy indications;
  • 2. Patients between 20 and 75 years old;
  • 3. Patients whose chemotherapy regimens are mainly AC regimens or contain platinum;
  • 4. Patients whose expected survival time is more than 6 months;
  • 5. Patients with ECoG score 0-2;
  • 6. The patients who voluntarily participated in the study signed the informed consent.

排除标准

  • 1. Patients with severe hepatic and renal insufficiency;
  • 2. Patients with coagulation dysfunction, thrombocytopenia or bleeding related diseases;
  • 3. Patients with refractory vomiting not caused by chemotherapy or existed before chemotherapy;
  • 4. Patients with mental disorders;
  • 5. Patients with hypotension;
  • 6. Patients with edema, infection, ulceration or skin disease at acupuncture site;
  • 7. Patients who feel dizzy, afraid of needling and blood sickness.

研究者

发起方
China-Japan Friendship Hospital

相似试验